Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Fakih

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Oncotarget|February 9, 2017
Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experienceJun Gong, May Cho, Marvin Sy, et al.
Clinical Colorectal Cancer|August 16, 2005
Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new, and novel approach for the treatment of solid tumorsMarwan Fakih, Shousong Cao, Farukh A Durrani, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 8, 2021
Rationale and Design of a Telehealth Self-Management, Shared Care Intervention for Post-treatment Survivors of Lung and Colorectal CancerVirginia Sun, Anne Reb, Marc Debay, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 23, 2021
Correction to: Rationale and Design of a Telehealth Self-Management, Shared Care Intervention for Post-treatment Survivors of Lung and Colorectal CancerVirginia Sun, Anne Reb, Marc Debay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2024
Updated survival outcome of regorafenib, ipilimumab, and nivolumab in refractory microsatellite stable non-liver metastatic colorectal cancer: A phase I nonrandomized clinical trialAnnie Xiao, Xiaochen Li, Chongkai Wang, et al.
Clinical Colorectal Cancer|June 23, 2022
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal CancerJeremy Chuang, Jun Gong, Sierra Min Li, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a <i>POLE</i> MutationJun Gong, Chongkai Wang, Peter P Lee, et al.
The Oncologist|May 15, 2020
Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal CancerChongkai Wang, Dawnyel Chevalier, Janelle Saluja, et al.
The Oncologist|March 13, 2020
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal CancerRohan Gupta, Tamer Othman, Chen Chen, et al.
Toxicology and Applied Pharmacology|February 27, 2007
Selenium metabolites in urine of cancer patients receiving L-selenomethionine at high dosesDoris Kuehnelt, Dijana Juresa, Kevin A Francesconi, et al.
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Oncotarget|February 9, 2017
Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experienceJun Gong, May Cho, Marvin Sy, et al.
Clinical Colorectal Cancer|August 16, 2005
Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new, and novel approach for the treatment of solid tumorsMarwan Fakih, Shousong Cao, Farukh A Durrani, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 8, 2021
Rationale and Design of a Telehealth Self-Management, Shared Care Intervention for Post-treatment Survivors of Lung and Colorectal CancerVirginia Sun, Anne Reb, Marc Debay, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 23, 2021
Correction to: Rationale and Design of a Telehealth Self-Management, Shared Care Intervention for Post-treatment Survivors of Lung and Colorectal CancerVirginia Sun, Anne Reb, Marc Debay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2024
Updated survival outcome of regorafenib, ipilimumab, and nivolumab in refractory microsatellite stable non-liver metastatic colorectal cancer: A phase I nonrandomized clinical trialAnnie Xiao, Xiaochen Li, Chongkai Wang, et al.
Clinical Colorectal Cancer|June 23, 2022
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal CancerJeremy Chuang, Jun Gong, Sierra Min Li, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
Response to PD-1 Blockade in Microsatellite Stable Metastatic Colorectal Cancer Harboring a <i>POLE</i> MutationJun Gong, Chongkai Wang, Peter P Lee, et al.
The Oncologist|May 15, 2020
Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal CancerChongkai Wang, Dawnyel Chevalier, Janelle Saluja, et al.
The Oncologist|March 13, 2020
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal CancerRohan Gupta, Tamer Othman, Chen Chen, et al.
Toxicology and Applied Pharmacology|February 27, 2007
Selenium metabolites in urine of cancer patients receiving L-selenomethionine at high dosesDoris Kuehnelt, Dijana Juresa, Kevin A Francesconi, et al.
Pageof 20